...
首页> 外文期刊>Polymers >pH-Responsive Tumor-Targetable Theranostic Nanovectors Based on Core Crosslinked (CCL) Micelles with Fluorescence and Magnetic Resonance (MR) Dual Imaging Modalities and Drug Delivery Performance
【24h】

pH-Responsive Tumor-Targetable Theranostic Nanovectors Based on Core Crosslinked (CCL) Micelles with Fluorescence and Magnetic Resonance (MR) Dual Imaging Modalities and Drug Delivery Performance

机译:基于核心交联(CCL)胶束的具有荧光和磁共振(MR)双重成像模式的pH响应性肿瘤靶向治疗性纳米载体

获取原文
           

摘要

The development of novel theranostic nanovectors is of particular interest in treating formidable diseases (e.g., cancers). Herein, we report a new tumor-targetable theranostic agent based on core crosslinked (CCL) micelles, possessing tumor targetable moieties and fluorescence and magnetic resonance (MR) dual imaging modalities. An azide-terminated diblock copolymer, N 3 -POEGMA- b -P(DPA- co -GMA), was synthesized via consecutive atom transfer radical polymerization (ATRP), where OEGMA, DPA, and GMA are oligo(ethylene glycol)methyl ether methacrylate, 2-(diisopropylamino)ethyl methacrylate, and glycidyl methacrylate, respectively. The resulting diblock copolymer was further functionalized with DOTA( Gd ) (DOTA is 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakisacetic acid) or benzaldehyde moieties via copper(I)-catalyzed alkyne-azide cycloaddition (CuAAC) chemistry, resulting in the formation of DOTA( Gd )-POEGMA- b -P(DPA- co -GMA) and benzaldehyde-POEGMA- b -P(DPA- co -GMA) copolymers. The resultant block copolymers co-assembled into mixed micelles at neutral pH in the presence of tetrakis[4-(2-mercaptoethoxy)phenyl]ethylene (TPE-4SH), which underwent spontaneous crosslinking reactions with GMA residues embedded within the micellar cores, simultaneously switching on TPE fluorescence due to the restriction of intramolecular rotation. Moreover, camptothecin (CPT) was encapsulated into the crosslinked cores at neutral pH, and tumor-targeting pH low insertion peptide (pHLIP, sequence: AEQNPIYWARYADWLFTTPLLLLDLALLVDADEGTCG) moieties were attached to the coronas through the Schiff base chemistry, yielding a theranostic nanovector with fluorescence and MR dual imaging modalities and tumor-targeting capability. The nanovectors can be efficiently taken up by A549 cells, as monitored by TPE fluorescence. After internalization, intracellular acidic pH triggered the release of loaded CPT, killing cancer cells in a selective manner. On the other hand, the nanovectors labeled with DOTA( Gd ) contrast agents exhibited increased relaxivity ( r 1 = 16.97 mM ?1 ·s ?1 ) compared to alkynyl-DOTA( Gd ) small molecule precursor ( r 1 = 3.16 mM ?1 ·s ?1 ). Moreover, in vivo MRI (magnetic resonance imaging) measurements revealed CCL micelles with pHLIP peptides exhibiting better tumor accumulation and MR imaging performance as well.
机译:在治疗可怕的疾病(例如癌症)中,新型治疗学纳米载体的开发特别令人感兴趣。本文中,我们报告了一种基于核心交联(CCL)胶束的新型肿瘤靶向治疗药物,它具有肿瘤靶向部分以及荧光和磁共振(MR)双重成像方式。通过连续原子转移自由基聚合(ATRP)合成了叠氮化物封端的二嵌段共聚物N 3 -POEGMA- b -P(DPA- co -GMA),其中OEGMA,DPA和GMA是低聚(乙二醇)甲基醚甲基丙烯酸酯,甲基丙烯酸2-(二异丙基氨基)乙酯和甲基丙烯酸缩水甘油酯。通过铜(I)催化的炔-叠氮化物环加成反应,用DOTA(Gd)(DOTA为1,4,7,10-四氮杂环十二烷-1,4,7,10-四烷基乙酸)或苯甲醛部分进一步官能化所得的二嵌段共聚物。 (CuAAC)化学,导致形成DOTA(Gd)-POEGMA- b -P(DPA- co -GMA)和苯甲醛-POEGMA- b -P(DPA- co -GMA)共聚物。所得的嵌段共聚物在四[4-(2-巯基乙氧基)苯基]乙烯(TPE-4SH)存在下,在中性pH下共组装成混合胶束,该胶与嵌入胶束核心的GMA残基同时进行自发交联反应由于分子内旋转的限制而开启TPE荧光。此外,喜树碱(CPT)在中性pH下被封装到交联的核中,并且靶向肿瘤的pH低插入肽(pHLIP,序列:AEQNPIYWARYADWLFTTPLLLLDLALLVDADEGTCG)部分通过席夫碱化学方法与电晕相连,从而产生具有荧光和MR双重成像方式和肿瘤靶向能力。通过TPE荧光监测,纳米载体可以被A549细胞有效吸收。内化后,细胞内酸性pH触发了负载的CPT的释放,以选择性方式杀死癌细胞。另一方面,与炔基-DOTA(Gd)小分子前体(r 1 = 3.16 mM?1)相比,用DOTA(Gd)造影剂标记的纳米载体表现出增加的弛豫性(r 1 = 16.97 mM?1·s?1) ·s?1)。此外,体内MRI(磁共振成像)测量显示带有pHLIP肽的CCL胶束也表现出更好的肿瘤蓄积和MR成像性能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号